![](https://news.europawire.eu/wp-content/uploads/2024/11/Boehringer-Ingelheim-Introduces-VETMEDIN®-Solution-a-Liquid-Treatment-for-Canine-Heart-Failure-144x144.webp)
(IN BRIEF) Boehringer Ingelheim has launched VETMEDIN® Solution, the first FDA-approved liquid treatment for congestive heart failure (CHF) in dogs caused by myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM). The solution provides a convenient, twice-daily alternative to tablets, … Read the full press release